AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

DNA Brands, Inc.

$0 +$0.00 (+0.00%)
OTC · 14 Sep 2026 20:00 UTC
Previous Close
$0
Day Range
$0 - $0
Year Range
$0$0
Market Cap
171.82K
AVG Volume
21.48K
Trailing/Forward PE
-0.8/-
PEG ratio
-0.01
Dividend Yield
-
Next Earnings Date
-
Primary Exchange
Other OTCUS
Revenue (USD)
0200K400K600K2013201620172018201920202021202220232024
DNAX Revenue (USD) by year
PeriodRevenue (USD)
20240
20230
20220
2021459.33K
2020249.01K
201918.07K
20180
20170
20160
2013156.8K
Net Income (USD)
-4M-3M-2M-1M02013201620172018201920202021202220232024
DNAX Net Income (USD) by year
PeriodNet Income (USD)
2024-522.4K
2023-703.85K
2022-374.99K
2021-303.93K
2020-1.25M
2019-300.48K
2018-622.68K
2017-315.25K
2016-246.8K
2013-3.1M
Operating Income (USD)
-3M-2M-1M02013201620172018201920202021202220232024
DNAX Operating Income (USD) by year
PeriodOperating Income (USD)
2024-250.29K
2023-271.46K
2022-337.57K
2021-303.92K
2020-1.74M
2019-180.62K
2018-366.96K
2017-315.25K
2016-246.8K
2013-2.46M
EBITDA (USD)
-2M-1.5M-1M-500K0500K2013201620172018201920202021202220232024
DNAX EBITDA (USD) by year
PeriodEBITDA (USD)
2024-250.29K
202311.53K
2022-204.63K
2021-300.4K
2020-1.74M
2019-175.56K
2018-78.17K
2017-256.69K
2016-246.8K
2013-1.93M
Cash Flows (USD)
-2M-1.5M-1M-500K0500K201220132016201720182019202120222023
DNAX Cash Flows (USD) by year
PeriodCash Flows (USD)
20236.23K
2022-95.84K
2021-434.5K
2019-61.8K
2018-7.51K
2017-67.63K
20167.84K
2013-1.87M
2012-1.6M
EPS (USD)
-20000-15000-10000-500002013201620172018201920202021202220232024
DNAX EPS (USD) by year
PeriodEPS (USD)
2024-0
2023-0
2022-0
2021-0.04
2020-0.32
2019-1.54
2018-2.64
2017-13.62
2016-36.02
2013-16420.58
Expenses (USD)
01M2M3M2013201620172018201920202021202220232024
DNAX Expenses (USD) by year
PeriodExpenses (USD)
2024250.29K
2023274.47K
2022337.59K
2021759.73K
20201.99M
2019193.63K
2018294.93K
2017314.88K
2016247.14K
20132.43M
Cash & Debt (USD)
01M2M3M4MCashLong Term DebtShort Term Debt2012201320162017201820192021202220232024
DNAX Cash & Debt (USD) by year
PeriodCash & Debt (USD)
2024321
2023357
20221.71K
202166.68K
2019499
201862.3K
201746.07K
20169.14K
201361.34K
20120
Debt ratios
-6-4-202017201820192021202220232024
DNAX Debt ratios by year
PeriodDebt ratios
2024-4.11
2023-1.26
2022-0.91
2021-0.85
2019-2.64
2018-0.75
2017-0.24
Margins
-50%0%50%100%20122013201920202021
DNAX Margins by year
PeriodMargins
2021100%
20200%
201969.49%
2013-12.73%
201228.87%
Return on Capital
0%50%100%150%2012201320162017201820192021202220232024
DNAX Return on Capital by year
PeriodReturn on Capital
202410.68%
202320.82%
202214.5%
202120.37%
201910.98%
201825.62%
201718.44%
201612.92%
2013120.87%
201294%
Shares Outstanding
0200M400M600M800M2013201620172018201920202021202220232024
DNAX Shares Outstanding by year
PeriodShares Outstanding
2024742.75M
2023678.06M
2022533.78M
2021511.33M
20205.12M
2019529.49K
201839.81K
201729.73K
20160
20130
Book Value Per Share (USD)
-80-60-40-2002017201820192021202220232024
DNAX Book Value Per Share (USD) by year
PeriodBook Value Per Share (USD)
2024-0.01
2023-0
2022-0
2021-0
2019-5.17
2018-61.06
2017-57.51
Total Assets (USD)
0500K1M1.5M2012201320162017201820192021202220232024
DNAX Total Assets (USD) by year
PeriodTotal Assets (USD)
2024256.31K
2023256.35K
2022257.7K
20211.11M
201950.41K
2018103.29K
201747.05K
201610.13K
2013523.59K
2012316.67K
Employee Count
010203020082010201120122013
DNAX Employee Count by year
PeriodEmployee Count
20137
201210
201123
201017
20082
Free Cash Flow Yield
-300%-200%-100%0%100%med -14.67%Apr 19Jul 19Nov 19Feb 20Jun 22Dec 23Mar 24
DNAX Free Cash Flow Yield by year
PeriodFree Cash Flow Yield
Mar 24-27.66%
Mar 24-28.87%
Mar 24-27.66%
Mar 24-25.54%
Mar 24-24.59%
Feb 24-20.75%
Feb 24-20.75%
Feb 24-23.71%
Feb 24-23.71%
Jan 24-20.75%
Jan 24-25.54%
Jan 24-20.75%
Jan 24-22.13%
Dec 23-23.71%
Dec 23-25.14%
Dec 23-22%
Dec 23-20.71%
Dec 23-14.67%
Nov 23-14.67%
Nov 23-14.19%
Nov 23-14.67%
Nov 23-14.67%
Oct 23-16%
Oct 23-19.56%
Oct 23-17.6%
Oct 23-18.53%
Sep 23-17.6%
Jun 22-6.11%
Jun 22-5.66%
Jun 22-3.69%
Jun 22-3.53%
May 22-3.53%
May 22-2.88%
May 22-3.06%
May 22-3.4%
Apr 22-2.66%
Apr 22-2.66%
Apr 22-2.66%
Apr 22-2.45%
Apr 22-2.2%
Mar 20-62.08%
Mar 20-34.49%
Mar 20-44.34%
Mar 20-38.8%
Feb 20-38.8%
Feb 20-20.69%
Feb 20-28.22%
Feb 20-34.49%
Jan 20-32.68%
Jan 20-31.67%
Jan 20-23.88%
Jan 20-23.88%
Jan 20-31.04%
Dec 1928.76%
Dec 1932.46%
Dec 1920.87%
Dec 1915.38%
Nov 1919.48%
Nov 1917.19%
Nov 1920.87%
Nov 1920.87%
Nov 1914.68%
Oct 1917.92%
Oct 1918.26%
Oct 1920.87%
Oct 1920.87%
Sep 19-273.27%
Sep 19-273.27%
Sep 19-202.52%
Sep 19-178.22%
Aug 19-195.19%
Aug 19-163.96%
Aug 19-204.95%
Aug 19-195.19%
Aug 19-136.64%
Jul 19-64.05%
Jul 19-102.48%
Jul 19-54.65%
Jul 19-46.06%
Jun 19-12.26%
Jun 19-10.15%
Jun 19-7.26%
Jun 19-7.21%
May 19-5.33%
May 19-4.72%
May 19-7.67%
May 19-4.55%
May 19-3.93%
Apr 19-4.72%
Apr 19-6.25%
Apr 19-4.95%
Apr 19-2.62%
Mar 17-0.09%
Mar 17-0.09%
Mar 17-0.09%
Mar 17-0.09%
Feb 17-0.09%
Feb 17-0.09%
Feb 17-0.09%
Feb 17-0.09%
Price to Sales
0204060med 14.52Jul 21Oct 21Jan 22May 22Aug 22Dec 22Mar 23
DNAX Price to Sales by year
PeriodPrice to Sales
Mar 2323.23
Mar 2320.33
Mar 2314.52
Mar 2314.52
Feb 2322.65
Feb 2323.23
Feb 2317.42
Feb 2317.71
Jan 2316.26
Jan 2317.42
Jan 2314.52
Jan 2317.42
Dec 2222.65
Dec 2217.93
Dec 2212.33
Dec 2217.52
Dec 2231.07
Nov 2241.71
Nov 2239.2
Nov 2237.12
Nov 2216.68
Oct 2225.02
Oct 2223.88
Oct 2237.54
Oct 2237.54
Sep 2235.97
Sep 2216.61
Sep 2219.74
Sep 2229.37
Sep 2226.53
Aug 2234.66
Aug 2223.14
Aug 2219.26
Aug 2217.52
Jul 2226.96
Jul 2226.19
Jul 2226.38
Jul 2222.05
Jul 2217.33
Jun 2215.47
Jun 2216.7
Jun 2225.6
Jun 2226.83
May 2226.83
May 2232.84
May 2230.95
May 2227.83
Apr 2235.62
Apr 2235.62
Apr 2235.62
Apr 2238.57
Apr 2242.97
Mar 220.41
Mar 220.48
Mar 220.58
Mar 220.58
Feb 220.52
Feb 220.52
Feb 220.52
Feb 220.75
Jan 220.72
Jan 220.72
Jan 220.63
Jan 220.64
Dec 210.75
Dec 210.5
Dec 210.75
Dec 210.56
Dec 210.67
Nov 210.74
Nov 211.17
Nov 211.66
Nov 212.01
Oct 211.79
Oct 212.13
Oct 212.12
Oct 211.67
Oct 212.3
Sep 212.67
Sep 211.6
Sep 213.34
Sep 213.61
Aug 213.8
Aug 213.61
Aug 213.48
Aug 213.82
Jul 214
Jul 213.9
Jul 214.68
Jul 214.81
Jul 215.35
Jun 218.22
Jun 216.76
Jun 219.05
Jun 217.19
May 218.02
May 216.12
May 216.21
May 2112.13
Apr 2111.1
EV/EBITDA
0100200300med 53.24Oct 23Dec 23Jan 24Feb 24Apr 24May 24Jun 24
DNAX EV/EBITDA by year
PeriodEV/EBITDA
Jun 24267.24
Jun 24267.24
Jun 24267.24
Jun 24270.18
May 24276.06
May 24273.12
May 24273.12
May 24273.12
May 24273.12
Apr 24273.12
Apr 24267.24
Apr 24279
Apr 24284.88
Mar 2452.19
Mar 2451.92
Mar 2452.19
Mar 2452.71
Mar 2452.97
Feb 2454.29
Feb 2454.29
Feb 2453.24
Feb 2453.24
Jan 2454.29
Jan 2452.71
Jan 2454.29
Jan 2453.76
Dec 2353.24
Dec 238.2
Dec 238.34
Dec 238.41
Dec 238.9
Nov 238.9
Nov 238.95
Nov 238.9
Nov 238.9
Oct 238.76
Oct 238.48
Oct 238.62
Oct 238.55
Sep 238.62
Price/Operating Cashflow
34567med 4.79Oct 19Oct 19Nov 19Nov 19Nov 19Dec 19Dec 19
DNAX Price/Operating Cashflow by year
PeriodPrice/Operating Cashflow
Dec 193.48
Dec 193.08
Dec 194.79
Dec 196.5
Nov 195.13
Nov 195.82
Nov 194.79
Nov 194.79
Nov 196.81
Oct 195.58
Oct 195.48
Oct 194.79
Oct 194.79
DNA Brands, Inc.
DNAX
Stockpicker

Video analysis: DNAX

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.